Interview with Robert Dahan, President, AstraZeneca France
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
The Pfizer group has been established for over 50 years in France.
More than 3 000 employees who work daily in the various activities of the company, serving healthcare professionals and patients.
Clinical research: more than 80 physicians, pharmacists, scientists and technicians at the company headquarters in Paris and in different regions of France, ensure the proper conduct of clinical trials initiated by Pfizer
Production: 3 sites in the Val de Loire Alsace and Brittany, the Group’s employees contribute to Pfizer Manufacturing
Pharmaceutical Operations • Human health: employees with headquarters in Paris and visiting medical teams throughout the country. Pfizer is the first drug maker in the world and second in the French market
Cardiology
Pain
Endocrinology
Infectious disease
Ophthalmology
Oncology
Pulmonology
Rheumatology
Central Nervous System
Urology
Contact:
Address: 23-25 avenue du Dr. Lannelongue 75668 Paris Cedex 14,France
Tel: +33 (0)1 58 07 30 00
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
What are the main tasks of the LEEM? The LEEM is the only professional organization representing the pharmaceutical industry in France. It includes almost all companies which seek to develop,…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries. Given the variety of its membership…
US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is this a finished topic…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French one. Today the gap…
Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent has France kept up?…
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as much as possible activities…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
See our Cookie Privacy Policy Here
